Master Study of the Acticor/Rivacor ICDs/CRT-Ds and the Plexa ProMRI S DX Lead

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.

Also called NCT03891329

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 130 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03891329
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Austria, Germany, Hungary, Latvia, Netherlands, Slovakia, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03891329. Allocation not applicable; no masking; primary purpose other. Start 2019-04-30 (actual); primary completion 2020-12-21 (actual). Results posted on 2024-09-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Master Study of the Acticor/Rivacor ICDs/CRT-Ds and the Plexa ProMRI S DX Lead
Condition
Heart Failure
Condition
Tachyarrhythmia
Intervention (Device)
Acticor/Rivacor ICDs/CRT-Ds
Intervention (Device)
Plexa S DX
Lead sponsor
Biotronik SE & Co. KG (class: industry)

Record details

Record id
cardio:ct-nct03891329
Content hash
c243aa7ee60ba39d3fb79a1f4b26bfae141c94f1d4e8f5e9e97635a6745f2f03